Importantly, the incidence of CMV, which is the most frequent cause of viral infection in liver transplantation [112], was similar in liver transplant recipients receiving mTOR inhibitors compared to those receiving an alternative immunosuppressant, and in one study there was a trend to a lower incidence for sirolimus [57]. This evidence concerns the gene MTOR and viral infectious disease.